Press Release

May 27, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding
May 18, 2022 | Press Release
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
May 10, 2022 | Press Release
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners
April 12, 2022 | Press Release
Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson’s Disease
March 01, 2022 | Press Release
ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin
February 16, 2022 | Press Release
ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
November 16, 2021 | Press Release
Immunitas Therapeutics Names Amanda Wagner as CEO
September 08, 2021 | Press Release
Immunitas Therapeutics Appoints Seng-Lai ‘Thomas’ Tan, Ph.D. as Chief Scientific Officer
August 18, 2021 | Press Release
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases